Agenda
Agenda
8:30 AM Registration/Check-in Begins
9:00 AM Opening Remarks
Sangeeta Bhatia, MD, PhD – Massachusetts Institute of Technology
9:15 AM Endoplasmic reticulum and long-distance calcium signal integration in neurons
Jennifer Lippincott-Schwartz, PhD – Howard Hughes Medical Institute
9:40 AM How a Partnership of patients, researchers and clinicians can defeat even rare cancers. Lessons from Fibrolamellar Carcinoma
Sanford M. Simon, PhD – Rockefeller University
10:05 AM Microtalks (chosen from submitted abstracts)
10:20 AM Morning Break
10:40 AM Quo Vadis, Bile Acids?
Irwin M. Arias, MD – (Program Founder), National Institutes of Health
10:55 AM Bile acids as the master regulators of immunity in the liver
Siva Karthik Varanasi, PhD – U Mass Chan Medical School
11:20 AM Medical devices in the context of fibrosis
Ellen Roche, PhD – Massachusetts Institute of Technology
11:45 AM Microtalks (chosen from submitted abstracts)
12:00 PM Lunch – Poster Viewing & Judging
1:30 PM Developing microbiome-directed therapeutics for treating childhood undernutrition
Jeff Gordon, MD – WashU
1:55 PM Unseen, Undiagnosed: Finding Liver Fibrosis in the Community
Arpan Mohanty, MD, MSc – Boston University
2:20 PM Targeting Aging, Longevity and Rejuvenation
Vadim Gladyshev, PhD – Harvard Medical School
2:45 PM Afternoon Break
3:15 PM Spatially resolved single-cell genomics and functional genomics
Xiaowei Zhuang, PhD – Harvard University and Howard Hughes Medical Institute
3:40 PM Hepatic stellate cell plasticity and memory in chronic liver disease
Shuang Wang, PhD – Mount Sinai
4:05 PM “The Road Not Taken”: My Unusual Path from Chemical Engineering to Nanotechnology to Advances in Biology and Medicine.
Robert S. Langer, ScD – Massachusetts Institute of Technology
4:30 PM Closing Remarks & Awards Presentations
Wolfram Goessling, MD, PhD, Yale School of Medicine
Lorraine Stiehl, Chief Executive Officer – American Liver Foundation
4:45 PM Wine & Cheese Reception
Join this one-day virtual event to hear from leading biomedical scientists and physicians as they present critical research bridging basic science and liver disease.
Plenary speakers include:
Adjoa Anyane-Yeboa, MD MPH
Institution: Division of Gastroenterology Department of Medicine Massachusetts General Hospital Harvard Medical School
Lew Cantley, PhD
Institution: Dana Farber Cancer Institute
Presentation Title: Altered liver metabolism confounds the effectiveness of PI3K inhibitors for treating breast and endometrial cancers
Hans Clevers, PhD
Institution: Roche/Hubrecht Institute
Presentation Title: Organoids to model human diseases
Nikla Emambokus, PhD
Institution: Editor-in-Chief, Med; Executive Editor Med, Cell Metabolism
Heather Francis, PhD
Institution: Indiana University
Presentation Title: Regulation of Chronic Liver Disease and Cholangiopathies by Mast Cells
Stacey Huppert, PhD
Institution: Cincinnati Children’s
Presentation Title: Hepatic Epithelial Development and Plasticity- Identity and Commitment
Sonja Schrepfer, MD, PhD
Institution: Cincinnati Children’s
Presentation Title: Protecting transplanted cells from immune rejection is the key to unlocking the potential of regenerative medicine
Bao-Liang Song, PhD
Institution: Wuhan University
Presentation Title: Inhibition of ASGRI decreases lipid levels by promoting cholesterol excretion
Elizabeth K Speliotes MD, PhD, MPH
Institution: University of Michigan
Presentation Title: Genetic Subtyping of NAFLD
Joseph Takahashi, PhD
Institution: UT Southwestern
Presentation Title: Circadian clocks and their importance for metabolism, aging and longevity
Giovanni Traverso, MD, PhD
Institution: MIT, Brigham & Women’s Hospital, Harvard Medical School
Presentation Title: Explant liver model for drug development
Aubrey Weigel, PhD
Institution: Howard Hughes Medical Institute
Presentation Title: Towards Automatic Segmentation of Organelles in vEM
Hao Zhu, MD, PhD
Institution: UT Southwestern
Presentation Title: Clone Wars: Evolution of Adaptation and Malignancy in the liver
Hosted by:
- Sangeeta Bhatia, MD, PhD – Massachusetts Institute of Technology
- Wolfram Goessling, MD, PhD – Massachusetts General Hospital